Ticker ATNM – Actinium Pharmaceuticals – sales, description, marketcap – Tickerday.com

ATNM

Actinium Pharmaceuticals

–

Index: NYSE; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 127.97M; Volume: 109.58K; AvgVol 3m: 578.19K; Beta: 1.34;

Cost estimate:

P/E: –; EPS: -3.44; EPS growth quarter/prev quarter: 59.20%;

EPS growth this year: 34.20%; EPS growth past 5 years: 30.50%;

EPS ttm: -3.44;

P/S: ; P/B: 2.22; P/Cashflow: 2.55; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -93.20%; ROE – return on equity: -124.00%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.01;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 0.90%; Insider Transactions:0.00%;

Institutional Ownership: 25.00%; Institutional Transactions: 434.00%;

Data update: 07.10.2020.